Association of macular perfusion status with microvascular parameters up to the far periphery in diabetic retinopathy using multimodal imaging.

DR severity Diabetic retinopathy FA Retinal ischemia SSOCTA UWF

Journal

International journal of retina and vitreous
ISSN: 2056-9920
Titre abrégé: Int J Retina Vitreous
Pays: England
ID NLM: 101677897

Informations de publication

Date de publication:
04 Nov 2020
Historique:
received: 15 06 2020
accepted: 26 10 2020
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 10 12 2020
Statut: epublish

Résumé

The aim of our study was to investigate a possible association between macular perfusion status and retinal ischemia and leakage up to far peripheral retinal areas in eyes with early to advanced stages of diabetic retinopathy (DR). In a retrospective, cross sectional analysis ultrawide field (UWF) color fundus photos (Optos, Optomap California) were graded for DR severity. Foveal avascular zone (FAZ) and vessel density from the superficial (SCP) and deep capillary plexus (DCP) were assessed on optical coherence tomography angiography (OCTA) scans (Topcon, DRI-OCT Triton). UWF angiography images were used to quantify leakage/ischemic index and number of microaneurysms (MA). Age, gender, disease duration, type of diabetes, HbA1C, hypertension, complications of diabetes and ocular history were recorded. Univariate mixed models and Spearman correlation analysis were used for statistical testing. 24 eyes of 17 laser-naive diabetic patients with different stages of DR were analyzed. The mean age was 59.56 ± 8.46 years and the mean disease duration 19.65 ± 12.25 years. No statistically significant associations between FAZ size, macular vessel density of SCP/DCP and peripheral retinal ischemia, leakage and MA number were demonstrated. Higher stages of DR were associated with ischemic index (estimate [95% CI]: 13.04 [1.5; 24.5], p = 0.033) and MA count (estimate [95% CI]: 43.7 [15.6; 71.8], p = 0.01), but no association with leakage index was observed. Only weak correlations between DR severity and anamnestic data were found. Retinal ischemic index and the amount of MAs assessed on UWFA up to peripheral areas are indicators of DR severity but not related to microvascular perfusion status in the macular region. Significance and timely sequence of macular vessel density in DR progression may need to be re-evaluated in future studies.

Sections du résumé

BACKGROUND BACKGROUND
The aim of our study was to investigate a possible association between macular perfusion status and retinal ischemia and leakage up to far peripheral retinal areas in eyes with early to advanced stages of diabetic retinopathy (DR).
METHODS METHODS
In a retrospective, cross sectional analysis ultrawide field (UWF) color fundus photos (Optos, Optomap California) were graded for DR severity. Foveal avascular zone (FAZ) and vessel density from the superficial (SCP) and deep capillary plexus (DCP) were assessed on optical coherence tomography angiography (OCTA) scans (Topcon, DRI-OCT Triton). UWF angiography images were used to quantify leakage/ischemic index and number of microaneurysms (MA). Age, gender, disease duration, type of diabetes, HbA1C, hypertension, complications of diabetes and ocular history were recorded. Univariate mixed models and Spearman correlation analysis were used for statistical testing.
RESULTS RESULTS
24 eyes of 17 laser-naive diabetic patients with different stages of DR were analyzed. The mean age was 59.56 ± 8.46 years and the mean disease duration 19.65 ± 12.25 years. No statistically significant associations between FAZ size, macular vessel density of SCP/DCP and peripheral retinal ischemia, leakage and MA number were demonstrated. Higher stages of DR were associated with ischemic index (estimate [95% CI]: 13.04 [1.5; 24.5], p = 0.033) and MA count (estimate [95% CI]: 43.7 [15.6; 71.8], p = 0.01), but no association with leakage index was observed. Only weak correlations between DR severity and anamnestic data were found.
CONCLUSION CONCLUSIONS
Retinal ischemic index and the amount of MAs assessed on UWFA up to peripheral areas are indicators of DR severity but not related to microvascular perfusion status in the macular region. Significance and timely sequence of macular vessel density in DR progression may need to be re-evaluated in future studies.

Identifiants

pubmed: 33292856
doi: 10.1186/s40942-020-00253-w
pii: 10.1186/s40942-020-00253-w
pmc: PMC7640640
doi:

Types de publication

Journal Article

Langues

eng

Pagination

50

Références

Retina. 2008 Oct;28(8):1053-60
pubmed: 18779710
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):30-34
pubmed: 28114569
Ophthalmol Retina. 2019 Oct;3(10):843-849
pubmed: 31302104
Retina. 2019 Mar;39(3):426-434
pubmed: 30664126
Clin Ophthalmol. 2017 Apr 27;11:803-807
pubmed: 28490862
Int J Retina Vitreous. 2019 Dec 10;5:41
pubmed: 31867124
Asia Pac J Ophthalmol (Phila). 2018 Jan-Feb;7(1):46-51
pubmed: 29436208
Sci Rep. 2020 Jan 30;10(1):1474
pubmed: 32001769
Ophthalmology. 2009 Sep;116(9):1755-61
pubmed: 19560206
Ophthalmology. 1981 Jul;88(7):601-12
pubmed: 6167923
Ophthalmol Retina. 2018 Jan;2(1):46-52
pubmed: 31047302
Clin Ophthalmol. 2013;7:173-8
pubmed: 23355773
Retina. 2019 Mar;39(3):435-445
pubmed: 29206758
Clin Ophthalmol. 2015 Mar 24;9:527-31
pubmed: 25848202
Ophthalmology. 2003 Sep;110(9):1677-82
pubmed: 13129861
Retina. 2020 Oct;40(10):1964-1971
pubmed: 31800461
Ophthalmology. 1991 May;98(5 Suppl):807-22
pubmed: 2062514
Am J Ophthalmol. 2014 Jul;158(1):144-153.e1
pubmed: 24709807
Ophthalmology. 2019 Dec;126(12):1685-1694
pubmed: 31383483
J Ophthalmic Vis Res. 2016 Jan-Mar;11(1):84-92
pubmed: 27195091
Ophthalmology. 2013 Dec;120(12):2587-2595
pubmed: 23778092
Int Ophthalmol. 2019 Oct;39(10):2361-2371
pubmed: 31119505
Ophthalmol Retina. 2019 Jul;3(7):580-588
pubmed: 31078525
BMJ Open. 2019 Mar 3;9(3):e022188
pubmed: 30833309
Retina. 2020 Mar;40(3):412-420
pubmed: 30576300
Br J Ophthalmol. 2012 May;96(5):694-8
pubmed: 22423055
Br J Ophthalmol. 2014 Dec;98(12):1612-7
pubmed: 25091952
JAMA Ophthalmol. 2018 Apr 1;136(4):315-321
pubmed: 29494727
Ophthalmology. 2019 Nov;126(11):1527-1532
pubmed: 31383482
Arch Ophthalmol. 1975 Dec;93(12):1300-10
pubmed: 1200895
Ophthalmology. 2015 Dec;122(12):2465-72
pubmed: 26350546
Retina. 2012 Apr;32(4):785-91
pubmed: 22080911
Retina. 2013 Sep;33(8):1630-9
pubmed: 23492950
Ophthalmology. 1984 Dec;91(12):1431-9
pubmed: 6084212
JAMA Ophthalmol. 2017 Jun 1;135(6):558-568
pubmed: 28448655

Auteurs

Dorottya Hajdu (D)

Department of Ophthalmology and Optometry, Vienna Clinical Trial Centre (VTC), Medical University of Vienna, Waehringer Guertel 18-20, E8i, 1090, Vienna, Austria.

Aleksandra Sedova (A)

Department of Ophthalmology and Optometry, Vienna Clinical Trial Centre (VTC), Medical University of Vienna, Waehringer Guertel 18-20, E8i, 1090, Vienna, Austria.

Felix Datlinger (F)

Department of Ophthalmology and Optometry, Vienna Clinical Trial Centre (VTC), Medical University of Vienna, Waehringer Guertel 18-20, E8i, 1090, Vienna, Austria.

Julia Hafner (J)

Department of Ophthalmology and Optometry, Vienna Clinical Trial Centre (VTC), Medical University of Vienna, Waehringer Guertel 18-20, E8i, 1090, Vienna, Austria.

Irene Steiner (I)

Center for Medical Statistics, Informatics, and Intelligent Systems (CeMSIIS), Section for Medical Statistics, Medical University of Vienna, Vienna, Austria.

Katharina Kriechbaum (K)

Department of Ophthalmology and Optometry, Vienna Clinical Trial Centre (VTC), Medical University of Vienna, Waehringer Guertel 18-20, E8i, 1090, Vienna, Austria.

Christoph Scholda (C)

Department of Ophthalmology and Optometry, Vienna Clinical Trial Centre (VTC), Medical University of Vienna, Waehringer Guertel 18-20, E8i, 1090, Vienna, Austria.

Stefan Sacu (S)

Department of Ophthalmology and Optometry, Vienna Clinical Trial Centre (VTC), Medical University of Vienna, Waehringer Guertel 18-20, E8i, 1090, Vienna, Austria.

Ursula Schmidt-Erfurth (U)

Department of Ophthalmology and Optometry, Vienna Clinical Trial Centre (VTC), Medical University of Vienna, Waehringer Guertel 18-20, E8i, 1090, Vienna, Austria.
Christian Doppler Laboratory for Ophthalmic Image Analysis, Vienna Reading Center, Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Andreas Pollreisz (A)

Department of Ophthalmology and Optometry, Vienna Clinical Trial Centre (VTC), Medical University of Vienna, Waehringer Guertel 18-20, E8i, 1090, Vienna, Austria. andreas.pollreisz@meduniwien.ac.at.

Classifications MeSH